4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0001193125-25-211363
10% owner sold 135,304 shares at an average $42.23 ($5,714,356)
From the SEC's structured data for this filing
Trades in this filing
Versant Venture Capital VI, L.P. · 10% owner
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-18 | Sale : show line 1 in the form | −49,479 | $41.59 | $2,057,871 | 1,224,718 | D |
| 2025-09-18 | Sale : show line 2 in the form | −24,370 | $41.59 | $1,013,568 | 876,437 | I |
| 2025-09-18 | Sale : show line 3 in the form | −40,907 | $43.00 | $1,759,156 | 1,183,811 | D |
| 2025-09-18 | Sale : show line 4 in the form | −20,148 | $43.00 | $866,441 | 856,289 | I |
| 2025-09-18 | Sale : show line 5 in the form | −268 | $43.30 | $11,604 | 1,183,543 | D |
| 2025-09-18 | Sale : show line 6 in the form | −132 | $43.30 | $5,716 | 856,157 | I |
| Open-market sales · 135,304 sh · avg $42.23 · $5,714,356 | ||||||
Loading xslF345X05/ownership.xml…